Krystal Biotech, Inc. (KRYS)

Name: Krystal Biotech, Inc. (KRYS) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001711279 · Nasdaq · Biological Products, (No Diagnostic Substances)

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2025-12-31, Krystal Biotech, Inc. reported revenue of $389.13M. Revenue grew 33.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $440.48M.

Key ratios (year ended 2025-12-31)

41.5%

Operating margin

52.6%

Net margin

16.8%

Return on year-end equity

33.9%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$440.48M	$389.13M	$290.51M	$50.70M	$0	$0	n/a	n/a	n/a	n/a	n/a
R&D Expense	$59.23M	$58.05M	$53.58M	$46.43M	$42.46M	$27.88M	$17.94M	$15.62M	$7.76M	$3.21M	$741.0K
Operating Income	n/a	$161.29M	$65.75M	-$109.62M	-$145.20M	-$68.28M	-$33.00M	-$22.08M	-$11.92M	-$4.77M	-$1.14M
Depreciation & Amortization	n/a	n/a	n/a	n/a	$4.05M	$2.77M	$1.85M	$1.09M	n/a	n/a	n/a
EBITDA	n/a	n/a	n/a	n/a	-$141.14M	-$65.51M	-$31.15M	-$20.99M	n/a	n/a	n/a
Net Income	$241.46M	$204.83M	$89.16M	$10.93M	-$139.97M	-$69.57M	-$32.17M	-$19.09M	-$10.89M	-$7.92M	-$1.15M
EPS (Diluted)	n/a	$6.84	$3.00	$0.39	-$5.49	-$3.13	-$1.71	n/a	n/a	n/a	n/a
Total Assets	$1.50B	$1.33B	$1.06B	$818.36M	$558.45M	$626.29M	$310.84M	$209.02M	$116.12M	$50.11M	$2.18M
Total Liabilities	$141.52M	$114.23M	$109.46M	$39.71M	$36.22M	$32.72M	$18.76M	$6.11M	$2.89M	$640.0K	$1.89M
Shareholders' Equity	$1.36B	$1.22B	$946.38M	$778.64M	$522.23M	$593.58M	$292.08M	$202.91M	$113.23M	$49.47M	$289.0K
Cash & Equivalents	$427.74M	$496.30M	$344.87M	$358.33M	$161.90M	$341.25M	$268.27M	$187.51M	$103.67M	$49.59M	$1.92M
Operating Cash Flow	$272.34M	$200.87M	$123.42M	-$88.80M	-$100.57M	-$47.94M	-$26.08M	-$18.69M	-$9.45M	n/a	n/a
Capital Expenditures	$14.56M	$11.95M	$4.24M	$11.80M	$52.98M	$68.34M	$14.84M	$6.40M	$2.23M	$210.0K	$15.0K
Free Cash Flow	$257.78M	$188.91M	$119.18M	-$100.60M	-$153.55M	-$116.27M	-$40.93M	-$25.09M	-$11.68M	n/a	n/a
Shares Outstanding	29.60M	29.19M	28.79M	28.24M	25.76M	25.21M	19.71M	17.35M	14.43M	10.31M	n/a
Weighted Average Diluted Shares	n/a	29.95M	29.74M	27.75M	25.49M	22.20M	18.79M	n/a	n/a	n/a	n/a
EPS (Basic)	n/a	$7.08	$3.12	$0.40	-$5.49	-$3.13	-$1.71	n/a	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView